Why is Infibeam Avenues falling/rising?
As of 02-Sep, Infibeam Avenues Ltd is currently priced at 15.83, showing a short-term gain but a significant year-to-date decline of 39.21%. Despite outperforming the Sensex recently, the stock's long-term performance remains concerning, leading to a cautious outlook among investors.
As of 02-Sep, Infibeam Avenues Ltd is experiencing a price increase, currently at 15.83, reflecting a change of 0.25 or 1.6% upward. The stock has shown a positive performance today, outperforming its sector by 1.53%. However, despite this short-term gain, the stock has a concerning long-term trajectory, with a year-to-date decline of 39.21% and a one-year return of -48.03%. The stock is currently trading above its 5-day and 20-day moving averages but below its longer-term moving averages, indicating mixed signals regarding its price momentum. Additionally, there has been a decline in investor participation, as evidenced by an 8.46% drop in delivery volume compared to the 5-day average.In the broader market context, Infibeam Avenues has outperformed the Sensex in the short term, with a 1-week return of +1.80% compared to the benchmark's -0.78%. Despite the positive short-term performance, the company has faced significant challenges over the longer term, including a substantial decline in stock value and underperformance relative to the BSE500 over multiple time frames. While the company boasts strong fundamentals, such as a low debt-to-equity ratio and consistent profit growth, these factors have not translated into positive stock performance in the long run, contributing to a cautious outlook among investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
